Enterovirus D68 Antivirals: Past, Present, and Future

被引:50
|
作者
Hu, Yanmei [1 ]
Musharrafieh, Rami [1 ]
Zheng, Madeleine [1 ]
Wang, Jun [1 ]
机构
[1] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
来源
ACS INFECTIOUS DISEASES | 2020年 / 6卷 / 07期
关键词
enterovirus D68; acute flaccid myelitis; antiviral;
D O I
10.1021/acsinfecdis.0c00120
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Enterovirus D68 (EV-D68) is an RNA virus that causes respiratory illnesses mainly in children. In severe cases, it can lead to neurological complications such as acute flaccid myelitis (AFM). EV-D68 belongs to the enterovirus genera of the Picornaviridae family, which also includes many other significant human pathogens such as poliovirus, enterovirus A71, and rhinovirus. There are currently no vaccines or antivirals against EV-D68. In this review, we present the current understanding of the link between EV-D68 and AFM, the mechanism of viral replication, and recent progress in developing EV-D68 antivirals by targeting various viral proteins and host factors that are essential for viral replication. The future directions of EV-D68 antiviral drug discovery and the criteria for drugs to reach clinical trials are also discussed.
引用
收藏
页码:1572 / 1586
页数:15
相关论文
共 50 条
  • [1] Acute flaccid myelitis and enterovirus D68: lessons from the past and present
    Jelte Helfferich
    Marjolein Knoester
    Coretta C. Van Leer-Buter
    Rinze F. Neuteboom
    Linda C. Meiners
    Hubert G. Niesters
    Oebele F. Brouwer
    European Journal of Pediatrics, 2019, 178 : 1305 - 1315
  • [2] Acute flaccid myelitis and enterovirus D68: lessons from the past and present
    Helfferich, Jelte
    Knoester, Marjolein
    Van Leer-Buter, Coretta C.
    Neuteboom, Rinze F.
    Meiners, Linda C.
    Niesters, Hubert G.
    Brouwer, Oebele F.
    EUROPEAN JOURNAL OF PEDIATRICS, 2019, 178 (09) : 1305 - 1315
  • [3] Enterovirus A71 antivirals: Past, present, and future
    Jun Wang
    Yanmei Hu
    Madeleine Zheng
    ActaPharmaceuticaSinicaB, 2022, 12 (04) : 1542 - 1566
  • [4] Enterovirus A71 antivirals: Past, present, and future
    Wang, Jun
    Hu, Yanmei
    Zheng, Madeleine
    ACTA PHARMACEUTICA SINICA B, 2022, 12 (04) : 1542 - 1566
  • [5] Discovery of Quinoline Analogues as Potent Antivirals against Enterovirus D68 (EV-D68)
    Musharrafieh, Rami
    Zhang, Jiantao
    Tuohy, Peter
    Kitamura, Naoya
    Bellampalli, Shreya Sai
    Hu, Yanmei
    Khanna, Rajesh
    Wang, Jun
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (08) : 4074 - 4090
  • [6] Enterovirus D68 Infection
    Esposito, Susanna
    Bosis, Samantha
    Niesters, Hubert
    Principi, Nicola
    VIRUSES-BASEL, 2015, 7 (11): : 6043 - 6050
  • [7] The enterovirus D68 epidemic
    Modlin, John F.
    LANCET RESPIRATORY MEDICINE, 2015, 3 (11): : 829 - 830
  • [8] Discovery and Optimization of Quinoline Analogues as Novel Potent Antivirals against Enterovirus D68
    Li, Xiaoyuan
    Li, Yuexiang
    Fan, Shiyong
    Cao, Ruiyuan
    Li, Xiaojia
    He, Xiaomeng
    Li, Wei
    Xu, Longfa
    Cheng, Tong
    Li, Honglin
    Zhong, Wu
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (21) : 14792 - 14808
  • [9] Enterovirus D68: A clinically important respiratory enterovirus
    Foster, Charles B.
    Friedman, Neil
    Carl, John
    Piedimonte, Giovanni
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2015, 82 (01) : 26 - 31
  • [10] Epidemiology of Enterovirus D68 in Ontario
    Peci, Adriana
    Winter, Anne-Luise
    Warshawsky, Bryna
    Booth, Tim F.
    Eshaghi, AliReza
    Li, Aimin
    Perusini, Stephen
    Olsha, Romy
    Marchand-Austin, Alex
    Kristjanson, Erik
    Gubbay, Jonathan B.
    PLOS ONE, 2015, 10 (11):